Checchi Capital Advisers, LLC Pfizer Inc Transaction History

Checchi Capital Advisers, LLC

$1.89 Billion
Q1 2025

A detailed history of Checchi Capital Advisers, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Checchi Capital Advisers, LLC holds 34,065 shares of PFE stock, worth $804,274. This represents 0.05% of its overall portfolio holdings.

Number of Shares

34,065

Previous 31,539 8.01%

Holding current value

$804,274

Previous $836,000 3.23%

% of portfolio

0.05%

Previous 0.05%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 28, 2025	BUY	$25.01 - $27.13 $63,175 - $68,530	2,526 Added 8.01%	34,065 $863,000
Q4 2024 Feb 04, 2025	SELL	$24.8 - $30.19 $260,052 - $316,572	-10,486 Reduced 24.95%	31,539 $836,000
Q3 2024 Nov 04, 2024	BUY	$27.7 - $31.39 $33,821 - $38,327	1,221 Added 2.99%	42,025 $1.22 Million
Q2 2024 Jul 26, 2024	SELL	$25.26 - $29.6 $67,090 - $78,617	-2,656 Reduced 6.11%	40,804 $1.14 Million
Q1 2024 Apr 25, 2024	SELL	$25.89 - $29.73 $30,446 - $34,962	-1,176 Reduced 2.63%	43,460 $1.21 Million
Q4 2023 Feb 07, 2024	SELL	$26.13 - $33.94 $280,871 - $364,821	-10,749 Reduced 19.41%	44,636 $1.29 Million
Q3 2023 Nov 09, 2023	SELL	$32.09 - $37.51 $253,478 - $296,291	-7,899 Reduced 12.48%	55,385 $1.84 Million
Q2 2023 Aug 09, 2023	SELL	$36.12 - $41.79 $177,818 - $205,732	-4,923 Reduced 7.22%	63,284 $2.32 Million
Q1 2023 May 05, 2023	SELL	$39.39 - $51.28 $18,040 - $23,486	-458 Reduced 0.67%	68,207 $2.78 Million
Q4 2022 Feb 10, 2023	SELL	$41.75 - $54.5 $146,709 - $191,513	-3,514 Reduced 4.87%	68,665 $3.52 Million
Q3 2022 Nov 09, 2022	BUY	$43.76 - $53.42 $15,491 - $18,910	354 Added 0.49%	72,179 $3.16 Million
Q2 2022 Aug 11, 2022	BUY	$46.53 - $55.17 $306,865 - $363,846	6,595 Added 10.11%	71,825 $3.63 Million
Q1 2022 May 09, 2022	BUY	$45.75 - $56.69 $152,484 - $188,947	3,333 Added 5.38%	65,230 $3.38 Million
Q4 2021 Feb 09, 2022	BUY	$41.32 - $61.25 $58,137 - $86,178	1,407 Added 2.33%	61,897 $3.66 Million
Q3 2021 Nov 09, 2021	SELL	$39.25 - $50.42 $140,711 - $180,755	-3,585 Reduced 5.6%	60,490 $2.6 Million
Q2 2021 Aug 06, 2021	SELL	$35.91 - $40.68 $104,749 - $118,663	-2,917 Reduced 4.35%	64,075 $2.51 Million
Q1 2021 May 10, 2021	SELL	$33.49 - $37.77 $33,891 - $38,223	-1,012 Reduced 1.49%	66,992 $2.43 Million
Q4 2020 Feb 12, 2021	BUY	$33.47 - $42.56 $22,491 - $28,600	672 Added 1.0%	68,004 $2.5 Million
Q3 2020 Nov 10, 2020	SELL	$31.75 - $37.25 $1,079 - $1,266	-34 Reduced 0.05%	67,332 $2.47 Million
Q2 2020 Aug 12, 2020	SELL	$30.12 - $36.54 $44,276 - $53,713	-1,470 Reduced 2.14%	67,366 $2.2 Million
Q1 2020 May 07, 2020	BUY	$27.03 - $38.62 $106,741 - $152,510	3,949 Added 6.09%	68,836 $2.25 Million
Q4 2019 Feb 07, 2020	BUY	$32.92 - $37.36 $57,247 - $64,969	1,739 Added 2.75%	64,887 $2.54 Million
Q3 2019 Nov 06, 2019	SELL	$32.49 - $42.13 $88,632 - $114,930	-2,728 Reduced 4.14%	63,148 $2.27 Million
Q2 2019 Aug 06, 2019	SELL	$36.98 - $41.52 $85,201 - $95,662	-2,304 Reduced 3.38%	65,876 $2.85 Million
Q1 2019 May 09, 2019	SELL	$37.5 - $41.2 $164,400 - $180,620	-4,384 Reduced 6.04%	68,180 $2.9 Million
Q4 2018 Feb 07, 2019	SELL	$38.47 - $43.86 $271,829 - $309,914	-7,066 Reduced 8.87%	72,564 $3.17 Million
Q3 2018 Oct 29, 2018	BUY	$34.47 - $41.81 $222,745 - $270,176	6,462 Added 8.83%	79,630 $3.51 Million
Q2 2018 Aug 06, 2018	BUY	$32.98 - $35.16 $124,301 - $132,518	3,769 Added 5.43%	73,168 $2.66 Million
Q1 2018 May 01, 2018	BUY	$31.91 - $37.02 $42,025 - $48,755	1,317 Added 1.93%	69,399 $2.46 Million
Q4 2017 Feb 02, 2018	BUY	$33.26 - $35.29 $86,609 - $91,895	2,604 Added 3.98%	68,082 $2.47 Million
Q3 2017 Nov 02, 2017	BUY	$31.0 - $34.15 $2.03 Million - $2.24 Million	65,478	65,478 $2.34 Million

Others Institutions Holding PFE

# of Institutions

3,365

Shares Held

3.6B

Call Options Held

102M

Put Options Held

130M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $133B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Checchi Capital Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Checchi Capital Advisers, LLC with notifications on news.

Account

Checchi Capital Advisers, LLC Pfizer Inc Transaction History